Bio-Manguinhos/Fiocruz COVID-19 (mRNA) Vaccine Booster | MicrobiomeTrials← Back to trialsNCT07640308
Bio-Manguinhos/Fiocruz COVID-19 (mRNA) Vaccine Booster
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-07Est. Completion: 2027-07
Enrollment target: 90 participants Other microbiome trials you might be interested in
SARS-CoV-2Influenza, HumanRespiratory Syncytial Virus InfectionsRespiratory Distress SyndromeSystemic Inflammatory Response Syndrome
The purpose of this clinical trial is to evaluate the safety, tolerability and efficacy of two doses (dose A and dose B)…
Alcalá de Henares, SpainEst. completion Oct 2, 2026
Rheumatoid Arthritis (RA)Systemic Lupus Erythematosus (SLE)Pemphigus Vulgaris
Multiple Sclerosis (MS)
Systemic Sclerosis (SSc)
Pediatric SLE
Juvenile Idiopathic Arthritis (JIA)
Juvenile Dermatomyositis (JDM)
Pediatric-Onset Multiple Sclerosis (POMS)
This is a randomized, multi-site, adaptive, open-label clinical trial comparing the immune response to different additio…
Los Angeles, United StatesCompleted Jun 22, 2023